Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-007682
Filing Date
2025-01-30
Accepted
2025-01-30 18:39:26
Documents
1
Period of Report
2025-01-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm254975-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm254975-1_4seq1.xml 4 6123
  Complete submission text file 0001104659-25-007682.txt   8623
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Reporting) CIK: 0001472322 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 25575232

Mailing Address C/O NANTAHALA CAPITAL MANAGEMENT, LLC 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address
Mack Daniel (Reporting) CIK: 0001775831 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 25575230

Mailing Address C/O NANTAHALA CAPITAL MANAGEMENT, LLC 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address
Harkey Wilmot B. (Reporting) CIK: 0001775952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 25575231